Latest News


ACTSI-supported Start-up Update: NeurOp

Created in 2007 as one of a national consortium striving to improve the way biomedical research is conducted across the country, the Atlanta Clinical & Translational Science Institute (ACTSI) works to break down obstacles in the translational...


CTSA Continues Support of BME Capstone Design Teams on Quest for Biomedical Solutions

One of the aims of the Research Technologies program is to develop and implement training programs that will supply investigators with skills and knowledge to traverse the idea path. To meet this aim, the program supports the Capstone Design...


CTSA Offers Study Design for Belatacept Clinical Trial

ACTSI's biostatistics program developed an optimal three-stage group sequential design for monitoring the safety of the clinical trial Bela 8 Week Dosing. The trial is examining immunosuppression therapy in post-transplant kidney recipients and is...


Former KL2 scholar receives two NIH R01 grants for HIV research

Colleen Kelley, MD, MPH, assistant professor of medicine at Emory University’s School of Medicine and Rollins School of Public Health and former Georgia CTSA KL2-Mentored Clinical and Translational Research Scholar, recently received two...


CTSA-supported Models Contribute to the First Possible Drug Treatment for Lymphedema

A recent study led by scientists at the Stanford University School of Medicine uncovered for the first time the molecular mechanism responsible for triggering lymphedema, as well as a drug with the potential for inhibiting that process....


A collaborative project with Georgia CTSA's biostatistics program & Emory Renal Medicine faculty drastically cuts infection in hemodialysis patients

Georgia CTSA's Biostatistics, Epidemiology, & Research Design (BERD) program collaborated on a quality improvement project to decrease catheter-related infections in hemodialysis patients led by Vandana Dua Niyyar, MD, associate professor of...

Upcoming Events

View All Events